Cara Therapeutics investor relations material
Listen to the latest call from Cara Therapeutics
Cara Therapeutics, Inc. is a biopharmaceutical company that focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States.
Ticker
CARACountry
US